Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/projekte/67-ibritumomab-tiuxetan-and-high-dose-melphalan-as-conditioning-regimen-before-autologous-stem-cell-transplantation-for-elderly-patients-with-lymphoma-in-relapse-or-resistant-to-chemotherapy-a-multicenter-phase-i-trial